CN112931741A - Dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health - Google Patents
Dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health Download PDFInfo
- Publication number
- CN112931741A CN112931741A CN201911340843.5A CN201911340843A CN112931741A CN 112931741 A CN112931741 A CN 112931741A CN 201911340843 A CN201911340843 A CN 201911340843A CN 112931741 A CN112931741 A CN 112931741A
- Authority
- CN
- China
- Prior art keywords
- percent
- powder
- extract
- seed
- assisting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 43
- 210000004369 blood Anatomy 0.000 title claims abstract description 39
- 239000008280 blood Substances 0.000 title claims abstract description 39
- 230000036772 blood pressure Effects 0.000 title claims abstract description 38
- 230000002526 effect on cardiovascular system Effects 0.000 title claims abstract description 36
- 235000005911 diet Nutrition 0.000 title claims abstract description 33
- 230000000378 dietary effect Effects 0.000 title claims abstract description 29
- 230000036541 health Effects 0.000 title claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 92
- 235000013361 beverage Nutrition 0.000 claims abstract description 38
- 239000007787 solid Substances 0.000 claims abstract description 35
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 32
- 235000012054 meals Nutrition 0.000 claims abstract description 29
- 240000007594 Oryza sativa Species 0.000 claims abstract description 24
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 24
- 235000009566 rice Nutrition 0.000 claims abstract description 24
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 18
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 18
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 18
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 17
- 235000013557 nattō Nutrition 0.000 claims abstract description 17
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 16
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 16
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 16
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 16
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 15
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 15
- 235000008434 ginseng Nutrition 0.000 claims abstract description 15
- 241000208688 Eucommia Species 0.000 claims abstract description 13
- 235000001188 Peltandra virginica Nutrition 0.000 claims abstract description 13
- URQMEZRQHLCJKR-UHFFFAOYSA-N 3-Methyl-5-propyl-2-cyclohexen-1-one Chemical compound CCCC1CC(C)=CC(=O)C1 URQMEZRQHLCJKR-UHFFFAOYSA-N 0.000 claims abstract description 12
- 240000006162 Chenopodium quinoa Species 0.000 claims abstract description 12
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 11
- 241000219784 Sophora Species 0.000 claims abstract description 11
- 235000020235 chia seed Nutrition 0.000 claims abstract description 10
- 235000015778 magnesium gluconate Nutrition 0.000 claims abstract description 9
- 239000001755 magnesium gluconate Substances 0.000 claims abstract description 9
- 229960003035 magnesium gluconate Drugs 0.000 claims abstract description 9
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 claims abstract description 9
- 229940026314 red yeast rice Drugs 0.000 claims abstract description 9
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 8
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 8
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 8
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 8
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 8
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 8
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 8
- 239000001168 astaxanthin Substances 0.000 claims abstract description 8
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 8
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 8
- 235000004426 flaxseed Nutrition 0.000 claims abstract description 8
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 7
- 235000011477 liquorice Nutrition 0.000 claims abstract description 7
- 239000001387 apium graveolens Substances 0.000 claims abstract description 6
- 235000004431 Linum usitatissimum Nutrition 0.000 claims abstract description 5
- 240000006240 Linum usitatissimum Species 0.000 claims abstract description 5
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 5
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 5
- 235000007558 Avena sp Nutrition 0.000 claims abstract 4
- 241001122767 Theaceae Species 0.000 claims description 39
- 235000013616 tea Nutrition 0.000 claims description 39
- 239000000203 mixture Substances 0.000 claims description 35
- 235000019197 fats Nutrition 0.000 claims description 30
- 230000002195 synergetic effect Effects 0.000 claims description 26
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims description 19
- 244000130270 Fagopyrum tataricum Species 0.000 claims description 19
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 17
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 17
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 17
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 17
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 17
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 17
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 17
- 240000000171 Crataegus monogyna Species 0.000 claims description 17
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 17
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 17
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 17
- 240000005979 Hordeum vulgare Species 0.000 claims description 16
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 16
- 244000197580 Poria cocos Species 0.000 claims description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 14
- 241000208340 Araliaceae Species 0.000 claims description 14
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims description 14
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims description 14
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 13
- 235000020334 white tea Nutrition 0.000 claims description 13
- 244000077995 Coix lacryma jobi Species 0.000 claims description 12
- 235000021307 Triticum Nutrition 0.000 claims description 12
- 241000209140 Triticum Species 0.000 claims description 12
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 11
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 11
- 244000302512 Momordica charantia Species 0.000 claims description 10
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 claims description 9
- 235000017615 Acanthopanax sessiliflorus Nutrition 0.000 claims description 9
- 244000167222 Acanthopanax sessiliflorus Species 0.000 claims description 9
- 235000014837 Malpighia glabra Nutrition 0.000 claims description 9
- 240000003394 Malpighia glabra Species 0.000 claims description 9
- 235000008708 Morus alba Nutrition 0.000 claims description 9
- 240000000249 Morus alba Species 0.000 claims description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- 235000015655 Crocus sativus Nutrition 0.000 claims description 8
- 244000124209 Crocus sativus Species 0.000 claims description 8
- 244000268590 Euryale ferox Species 0.000 claims description 8
- 241000123865 Gynura bicolor Species 0.000 claims description 8
- 244000234609 Portulaca oleracea Species 0.000 claims description 8
- 235000001855 Portulaca oleracea Nutrition 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 8
- 244000075850 Avena orientalis Species 0.000 claims description 7
- 241000220317 Rosa Species 0.000 claims description 7
- 235000019714 Triticale Nutrition 0.000 claims description 7
- 229930003427 Vitamin E Natural products 0.000 claims description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 7
- 235000019165 vitamin E Nutrition 0.000 claims description 7
- 229940046009 vitamin E Drugs 0.000 claims description 7
- 239000011709 vitamin E Substances 0.000 claims description 7
- 241000228158 x Triticosecale Species 0.000 claims description 7
- 235000006487 Euryale ferox Nutrition 0.000 claims description 6
- 235000013974 saffron Nutrition 0.000 claims description 6
- 239000004248 saffron Substances 0.000 claims description 6
- 241000205585 Aquilegia canadensis Species 0.000 claims description 5
- 229920001202 Inulin Polymers 0.000 claims description 5
- 244000131360 Morinda citrifolia Species 0.000 claims description 5
- 235000014441 Prunus serotina Nutrition 0.000 claims description 5
- 241001412173 Rubus canescens Species 0.000 claims description 5
- 230000003750 conditioning effect Effects 0.000 claims description 5
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 5
- 229940029339 inulin Drugs 0.000 claims description 5
- 235000017524 noni Nutrition 0.000 claims description 5
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 4
- 244000298697 Actinidia deliciosa Species 0.000 claims description 4
- 241000189662 Calla Species 0.000 claims description 4
- 241000931705 Cicada Species 0.000 claims description 4
- 241000371652 Curvularia clavata Species 0.000 claims description 4
- 241000233866 Fungi Species 0.000 claims description 4
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 4
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 4
- 244000017020 Ipomoea batatas Species 0.000 claims description 4
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 4
- 240000002624 Mespilus germanica Species 0.000 claims description 4
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 4
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 4
- 241000218093 Phedimus aizoon Species 0.000 claims description 4
- 244000252132 Pleurotus eryngii Species 0.000 claims description 4
- 235000001681 Pleurotus eryngii Nutrition 0.000 claims description 4
- 241001506047 Tremella Species 0.000 claims description 4
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 4
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 4
- 244000273928 Zingiber officinale Species 0.000 claims description 4
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 4
- 235000008397 ginger Nutrition 0.000 claims description 4
- 235000016709 nutrition Nutrition 0.000 claims description 4
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 claims description 3
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 claims description 3
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 claims description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 3
- 240000004510 Agastache rugosa Species 0.000 claims description 3
- 241000167854 Bourreria succulenta Species 0.000 claims description 3
- 235000007710 Grifola frondosa Nutrition 0.000 claims description 3
- 240000001080 Grifola frondosa Species 0.000 claims description 3
- 241000209035 Ilex Species 0.000 claims description 3
- 235000003332 Ilex aquifolium Nutrition 0.000 claims description 3
- 235000002296 Ilex sandwicensis Nutrition 0.000 claims description 3
- 235000002294 Ilex volkensiana Nutrition 0.000 claims description 3
- 240000007171 Imperata cylindrica Species 0.000 claims description 3
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 3
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims description 3
- 239000001556 apium graveolens l. seed extract Substances 0.000 claims description 3
- 229940116732 celery seed extract Drugs 0.000 claims description 3
- 235000019693 cherries Nutrition 0.000 claims description 3
- 235000004879 dioscorea Nutrition 0.000 claims description 3
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 244000025254 Cannabis sativa Species 0.000 claims description 2
- 235000008706 Ilex latifolia Nutrition 0.000 claims description 2
- 244000078118 Ilex latifolia Species 0.000 claims description 2
- 241001598107 Imperata Species 0.000 claims description 2
- 210000003813 thumb Anatomy 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims description 2
- 241000112528 Ligusticum striatum Species 0.000 claims 2
- 244000062793 Sorghum vulgare Species 0.000 claims 2
- 244000078534 Vaccinium myrtillus Species 0.000 claims 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims 2
- 241001529821 Agastache Species 0.000 claims 1
- 244000144725 Amygdalus communis Species 0.000 claims 1
- 235000011437 Amygdalus communis Nutrition 0.000 claims 1
- 235000002722 Dioscorea batatas Nutrition 0.000 claims 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims 1
- 240000001811 Dioscorea oppositifolia Species 0.000 claims 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims 1
- 241000222684 Grifola Species 0.000 claims 1
- 235000009936 Pteridium aquilinum Nutrition 0.000 claims 1
- 240000005893 Pteridium aquilinum Species 0.000 claims 1
- 241001162994 Rugosus Species 0.000 claims 1
- 235000010586 Sophora japonica Nutrition 0.000 claims 1
- 244000046101 Sophora japonica Species 0.000 claims 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims 1
- 244000126002 Ziziphus vulgaris Species 0.000 claims 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims 1
- 235000020224 almond Nutrition 0.000 claims 1
- 229940090949 docosahexaenoic acid Drugs 0.000 claims 1
- 235000011868 grain product Nutrition 0.000 claims 1
- 235000019713 millet Nutrition 0.000 claims 1
- 235000021018 plums Nutrition 0.000 claims 1
- 241000282414 Homo sapiens Species 0.000 abstract description 17
- 230000002490 cerebral effect Effects 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 5
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract description 5
- 230000001965 increasing effect Effects 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- 210000000582 semen Anatomy 0.000 abstract description 3
- 241000628997 Flos Species 0.000 abstract description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract description 2
- 235000019152 folic acid Nutrition 0.000 abstract description 2
- 239000011724 folic acid Substances 0.000 abstract description 2
- 229960000304 folic acid Drugs 0.000 abstract description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract 3
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 abstract 2
- 239000002075 main ingredient Substances 0.000 abstract 2
- 229960003512 nicotinic acid Drugs 0.000 abstract 2
- 241000209763 Avena sativa Species 0.000 abstract 1
- 240000001910 Momordica cochinchinensis Species 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 abstract 1
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 229930003537 Vitamin B3 Natural products 0.000 abstract 1
- 229930003761 Vitamin B9 Natural products 0.000 abstract 1
- 235000013402 health food Nutrition 0.000 abstract 1
- 235000001968 nicotinic acid Nutrition 0.000 abstract 1
- 239000011664 nicotinic acid Substances 0.000 abstract 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract 1
- 229940026510 theanine Drugs 0.000 abstract 1
- 235000019160 vitamin B3 Nutrition 0.000 abstract 1
- 239000011708 vitamin B3 Substances 0.000 abstract 1
- 235000019159 vitamin B9 Nutrition 0.000 abstract 1
- 239000011727 vitamin B9 Substances 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 20
- 230000000694 effects Effects 0.000 description 20
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
- 206010020772 Hypertension Diseases 0.000 description 11
- 239000013642 negative control Substances 0.000 description 10
- 208000026106 cerebrovascular disease Diseases 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 208000024172 Cardiovascular disease Diseases 0.000 description 8
- 208000031226 Hyperlipidaemia Diseases 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000013641 positive control Substances 0.000 description 7
- 230000009467 reduction Effects 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- 230000037213 diet Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 230000035488 systolic blood pressure Effects 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 108010028554 LDL Cholesterol Proteins 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000035487 diastolic blood pressure Effects 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000001631 hypertensive effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 241000212322 Levisticum officinale Species 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241001092459 Rubus Species 0.000 description 2
- 240000003829 Sorghum propinquum Species 0.000 description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000001645 levisticum officinale Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 229940057059 monascus purpureus Drugs 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229940013618 stevioside Drugs 0.000 description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 2
- 235000019202 steviosides Nutrition 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- PVHUJELLJLJGLN-INIZCTEOSA-N (S)-nitrendipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC([N+]([O-])=O)=C1 PVHUJELLJLJGLN-INIZCTEOSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000003417 Plumeria rubra f acutifolia Nutrition 0.000 description 1
- 244000040691 Plumeria rubra f. acutifolia Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- PFRQBZFETXBLTP-UHFFFAOYSA-N Vitamin K2 Natural products C1=CC=C2C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 235000020988 fatty fish Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000023589 ischemic disease Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- DKHGMERMDICWDU-GHDNBGIDSA-N menaquinone-4 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 DKHGMERMDICWDU-GHDNBGIDSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229940086319 nattokinase Drugs 0.000 description 1
- 108010073682 nattokinase Proteins 0.000 description 1
- 229960005425 nitrendipine Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229940075999 phytosterol ester Drugs 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000011885 synergistic combination Substances 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019143 vitamin K2 Nutrition 0.000 description 1
- 239000011728 vitamin K2 Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The embodiment of the invention relates to the technical field of health foods, and discloses a dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health, which comprises the following components: the solid beverage is one or more types of solid beverages which take red yeast rice, natto, ginseng powder, kudzu root, lotus leaf, sophora flower bud and the like as main components, or take celery powder, celery seed powder (extract), cassia seed, spina date seed, liquorice, tuckahoe, theanine, gamma-aminobutyric acid (GABA), short-stem acanthopanax powder (extract), astaxanthin, eucommia male flower, magnesium gluconate, vitamin B3 (nicotinic acid), vitamin B9 (folic acid) and the like as main components; one or more substitute tea comprising flos Chrysanthemi, Poria, herba Gynostemmatis, and Folum Ilicis as main ingredients, or fructus crataegi, folium Nelumbinis, Coicis semen, stigma croci Sativi, and semen Cassiae as main ingredients; and one or more meal replacement powders with balsam pear, quinoa rice, oat, linseed, chia seed and the like as main components. The dietary food provided by the invention can effectively play a role in assisting in reducing blood pressure and blood fat of a human body, promoting blood circulation to remove blood stasis, eliminating free radicals in the body, improving the oxidation resistance, protecting the health of heart and cerebral vessels and increasing the immunity of the human body.
Description
Technical Field
The invention relates to the technical field of food, in particular to a dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health.
Background
Cardiovascular and cerebrovascular diseases are the general names of cardiovascular and cerebrovascular diseases, and generally refer to ischemic or hemorrhagic diseases of heart, brain and systemic tissues caused by hyperlipidemia, blood viscosity, atherosclerosis, hypertension and the like. The cardiovascular and cerebrovascular diseases are common diseases seriously threatening the health of human beings, particularly the middle-aged and old people over 50 years old, and have the characteristics of high morbidity, high disability rate and high mortality, even if the most advanced and perfect treatment means is applied at present, more than 50 percent of cerebrovascular accident survivors can not completely live, the number of people dying from the cardiovascular and cerebrovascular diseases every year in the world reaches 1500 thousands, and the people live at the first of various causes of death.
Firstly, fresh vegetables, fruits and bean foods are rich in multiple vitamins, rich trace elements, antioxidants and dietary fibers, so that the effects of reducing blood pressure and protecting the cardiovascular system can be achieved, the dietary fibers can reduce the formation of cholesterol in a body, and the probability of coronary heart disease can be reduced; secondly, nut food and fatty fish food are excellent choices for auxiliary prevention of cardiovascular and cerebrovascular diseases.
In modern times, food with homology of medicine and food is often called as natural food and plays an important role in health care aspects such as disease prevention, resistance improvement and the like. From the function of plant secondary products, the plant secondary product is also the scientific material basis for generating the 'dietotherapy' function, and the food and the medicine have the same function and no clear limit in the aspect of regulating the physiological function of the human body and promote the generation of the 'dietotherapeutic food'.
The invention develops a dietary food which can assist in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health based on the principle of homology of medicine and food.
Disclosure of Invention
The invention aims to provide a dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health, which can adjust human physiological functions, thereby meeting the requirements of enhancing immunity and promoting the rehabilitation capacity of cardiovascular and cerebrovascular diseases.
In order to solve the technical problems, the embodiment of the invention provides a dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health, and the conditioning food comprises one or more of solid beverage, substitutive tea and substitutive meal powder;
wherein the solid beverage and the components thereof account for the following percentage of the total components: 2 to 5 percent of red yeast rice, 1 to 5 percent of natto, 1 to 3 percent of hawthorn powder (extract), 1 to 3 percent of acerola cherry powder, 1.5 to 3 percent of phytosterol (ester), 0.5 to 3 percent of eucommia male flower (extract), 1 to 3 percent of ginseng powder, 1 to 5 percent of kudzu root (extract), 0.1 to 3 percent of noni fruit enzyme powder, 1 to 2 percent of celery seed (extract), 3 to 5 percent of celery powder, 1 to 3 percent of mulberry leaf (extract), 0.5 to 2 percent of inulin, 1 to 5 percent of black cherry (extract), 1 to 3 percent of cassia seed (extract), 1 to 2 percent of spina date seed (extract), 0.5 to 3 percent of acanthopanax sessiliflorus (extract), 0.1 to 2 percent of tuckahoe (extract), 1 to 3 percent of lotus leaf (extract), 0.5 to 2 percent of gynostemma pentaphylla, 0.1 to 2 percent of rhizoma alismatis, 0.1 to 2 percent of rice, 0.1 to 2 percent of Szechuan lovage rhizome powder (extract), 0.5 to 2 percent of docosahexaenoic acid (DHA) powder, 0.001 to 0.1 percent of vitamin E, 0.5 to 1.5 percent of liquorice, 0.1 to 0.8 percent of gamma-aminobutyric acid (GABA), 0.05 to 0.75 percent of magnesium gluconate and 1 to 3 percent of astaxanthin.
The substitutional tea and the percentage of each component in the total components are as follows: 1 to 3 percent of honeysuckle, 0.1 to 2 percent of tuckahoe, 0.05 to 1 percent of wrinkled gianthyssop herb, 0.1 to 1 percent of saffron, 0.5 to 2 percent of gynostemma pentaphylla, 0.1 to 3 percent of cicada slough, 3 to 5 percent of chrysanthemum, 1 to 2 percent of cassia seed, 1 to 3 percent of coix seed, 2 to 5 percent of malt, 0.1 to 3 percent of fresh cogongrass rhizome, 1 to 2 percent of dried ginger, 2 to 3 percent of blackberry, 1 to 3 percent of orange peel, 2 to 3 percent of fried tartary buckwheat, 1 to 3 percent of rose, 2 to 3 percent of sophora flower, 1 to 3 percent of formosan lattuce herb, 3 to 5 percent of white tea spina date seed, 1 to 3 percent of hawthorn, 2 to 3 percent of lotus leaf.
The meal replacement powder comprises the following components in percentage by weight: 1 to 5 percent of sedum aizoon, 1 to 3 percent of sweet potato leaf, 0.5 to 3 percent of medlar bud, 1 to 3 percent of balsam pear, 0.5 to 2 percent of purslane, 1 to 2 percent of gynura bicolor, 0.5 to 2 percent of black fungus, 0.5 to 1 percent of tremella, 1 to 2 percent of calla, 1 to 3 percent of kiwi fruit, 0.1 to 2 percent of dried mulberry, 1 to 5 percent of sea-buckthorn pulp, 0.5 to 1 percent of spina date seed and 0.5 to 2 percent of dark plum, as well as 1 to 2 percent of black rice, 1 to 2 percent of sorghum rice, 1 to 3 percent of red glutinous rice, 1 to 3 percent of quinoa, 1 to 2 percent of yellow rice, 2 to 3 percent of barley bud powder or wheat bud powder, 1 to 3 percent of triticale, 1 to 2 percent of oat, 1 to 2 percent of tartary buckwheat, 1 to 2 percent of highland barley, 1 to 5 percent of yam, 0.5 to 1 percent of gorgon fruit, 0., 1 to 3 percent of abalone mushroom, 0.5 to 1 percent of pleurotus eryngii, 1 to 3 percent of grifola frondosa, 1 to 2 percent of fiddlehead, 0.5 to 1 percent of flaxseed and 0.5 to 1 percent of chia seed.
As a further embodiment of the invention, the solid beverage is a composition which can generate synergistic effect between at least one component and other components for protecting heart and brain blood vessels by assisting in reducing blood fat, and the composition comprises 2-5% of red yeast, 2-5% of natto, 1-3% of hawthorn powder (extract), 1-3% of acerola powder, 1.5-3% of phytosterol (ester), 1-3% of eucommia male flower extract, 1-3% of ginseng powder and 0.001-0.1% of vitamin E;
as a further embodiment of the invention, the solid beverage is a composition which can generate synergistic effect between at least one component and other components for protecting heart and cerebral vessels by assisting blood pressure reduction, and the composition comprises 1-3% of ginseng powder, 0.5-2% of acanthopanax sessiliflorus extract, 0.5-2% of eucommia male flower extract, 0.5-1.5% of sophora flower bud, 1.5-3% of lotus leaf extract, 1-2% of celery seed extract, 3-5% of celery powder, 1-2% of natto, 1-2% of cassia seed, 1-2% of spina date seed, 0.5-1.5% of liquorice, 0.5-1.5% of tuckahoe, 0.5-0.8% of GABA, 0.05-0.75% of magnesium gluconate and 1-3% of astaxanthin.
As a further embodiment of the invention, the substitutional tea is a composition which can generate a synergistic effect between at least one component for protecting cardiovascular and cerebrovascular by assisting in reducing blood fat and other components, and the composition comprises 3-5% of chrysanthemum, 0.1-2% of tuckahoe, 1-3% of orange peel, 2-3% of fried tartary buckwheat, 1-3% of rose, 0.5-2% of gynostemma pentaphylla, 1-2% of formosan lattuce herb and 3-5% of white tea;
as a further embodiment of the invention, the substitute tea is a composition which can generate a synergistic effect between at least one component for protecting cardiovascular and cerebrovascular by assisting blood pressure reduction and other components, and the composition comprises 1-3% of hawthorn, 2-3% of lotus leaf, 2-3% of fried tartary buckwheat, 1-3% of coix seed, 1-2% of cassia seed, 0.1-1% of saffron and 3-5% of white tea.
As a further embodiment of the present invention, the nutritional meal replacement powder is a composition having a synergistic effect between at least one component and other components, and the composition comprises 2.8% of bitter gourd, 1% of purslane, 1.5% of gynura bicolor, 0.6% of spina date seed, 2% of red glutinous rice, 2% of quinoa rice, 2% of triticale, 1.2% of oat, 1.2% of tartary buckwheat, 1.5% of highland barley, 0.6% of gorgon euryale seed, 0.8% of coix seed, 0.6% of linseed, 0.5% of chia seed, barley malt powder or 2% of wheat germ powder.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention more apparent, the embodiments of the present invention will be described in detail below. However, it will be appreciated by those of ordinary skill in the art that numerous technical details are set forth in order to provide a better understanding of the present invention in its various embodiments. However, the technical solution claimed in the present invention can be implemented without these technical details and various changes and modifications based on the following embodiments.
The embodiment of the invention provides a dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health, and the conditioning food comprises one or more of solid beverage, substitutive tea and substitutive meal powder;
wherein the solid beverage and the components thereof account for the following percentage of the total components: 2 to 5 percent of red yeast rice, 1 to 5 percent of natto, 1 to 3 percent of hawthorn powder (extract), 1 to 3 percent of acerola cherry powder, 1.5 to 3 percent of phytosterol (ester), 0.5 to 3 percent of eucommia male flower (extract), 1 to 3 percent of ginseng powder, 1 to 5 percent of kudzu root (extract), 0.1 to 3 percent of noni fruit ferment powder, 1 to 2 percent of celery seed (extract), 3 to 5 percent of celery powder, 1 to 3 percent of mulberry leaf (extract), 0.5 to 2 percent of inulin, 1 to 5 percent of black cherry (extract), 1 to 3 percent of cassia seed (extract), 1 to 2 percent of spina date seed (extract), 0.5 to 3 percent of acanthopanax sessiliflorus (extract), 0.1 to 2 percent of tuckahoe (extract), 1 to 3 percent of lotus leaf (extract), GABA, 0.5 to 2 percent of gynostemma pentaphylla, 0.1 to 2 percent of rhizoma alismatis, 0.1 to 2 percent of rice, 0.1 to 2 percent of Szechuan lovage rhizome powder (extract), 0.5 to 2 percent of docosahexaenoic acid (DHA) powder, 0.001 to 0.1 percent of vitamin E, 0.5 to 1.5 percent of liquorice, 0.1 to 0.8 percent of gamma-aminobutyric acid (GABA), 0.05 to 0.75 percent of magnesium gluconate and 1 to 3 percent of astaxanthin.
As a further embodiment of the invention, the solid beverage is a composition which can generate synergistic effect between at least one component and other components for protecting heart and brain blood vessels by assisting in reducing blood fat, and the composition comprises 2-5% of red yeast, 2-5% of natto, 1-3% of hawthorn powder (extract), 1-3% of acerola powder, 1.5-3% of phytosterol (ester), 1-3% of eucommia male flower extract, 1-3% of ginseng powder and 0.001-0.1% of vitamin E;
or, as a further embodiment of the present invention, the solid beverage is a composition that produces a synergistic effect between at least one component that protects cardiovascular and cerebrovascular by assisting blood pressure reduction and other components, and the composition comprises 1 to 3% of ginseng powder, 0.5 to 2% of acanthopanax sessiliflorus extract, 0.5 to 2% of eucommia male flower extract, 0.5 to 1.5% of sophora flower bud, 1.5 to 3% of lotus leaf extract, 1 to 2% of celery seed extract, 3 to 5% of celery powder, 1 to 2% of natto, 1 to 2% of cassia seed, 1 to 2% of spina date seed, 0.5 to 1.5% of licorice, 0.5 to 1.5% of poria cocos, 0.5 to 0.8% of gamma-aminobutyric acid (GABA), 0.05 to 0.75% of magnesium gluconate, and 1 to 3% of astaxanthin.
In the dietary food provided by the invention, one or more types of solid beverages which take red yeast rice, natto, ginseng powder and the like as main components can effectively play roles in assisting in reducing blood fat of a human body, protecting the health of heart and cerebral vessels and increasing the immunity of the human body.
In particular to natto which is rich in various physiologically active substances such as bacillus natto, high-quality small molecular protein (peptide), nattokinase, superoxide dismutase, biological polysaccharide, isoflavone, saponin, lecithin, dipicolinic acid, vitamin K2 and the like. The active substances can comprehensively regulate and improve four systems of human heart, cerebral vessels, bones, gastrointestinal tracts, immunity and the like, and can comprehensively improve the physical function and the immunity with unique effect;
in addition, the natto is combined with the components of hawthorn, mulberry leaf (extract), lotus leaf, phytosterol (ester) and the like to generate a synergistic effect, and the synergistic effect can effectively play a role in assisting in reducing the blood fat of a human body.
In the aspects of promoting blood circulation and improving human microcirculation: the composition of red yeast rice, ginseng powder, natto, rhizoma ligustici wallichii powder and other components can also generate synergistic effect.
The synergistic effect of the spina date seed and the acanthopanax sessiliflorus can effectively play a role in tranquilizing and allaying excitement.
In the aspect of oxidation resistance: the combination of acerola powder, black cherry, pagodatree flower bud, noni ferment and other components can also generate the synergistic effect.
The synergistic effect between celery powder and inulin can obviously regulate intestinal flora and promote digestion and elimination of human toxins.
In the aspect of diuresis: the invention discloses a synergistic combination of tuckahoe, celery seed and rhizoma alismatis.
The solid beverage provided by the invention has the following five aspects of effects: firstly, reducing blood fat; secondly, protecting blood vessels; thirdly, calming and improving sleep; fourthly, diuresis is realized, and blood pressure is reduced when water in blood is low; and fifthly, after improving the intestinal flora, the toxin absorption is less, and the insulin resistance is reduced.
The substitutional tea provided by the invention comprises the following components in percentage by weight: 1 to 3 percent of honeysuckle, 0.1 to 2 percent of tuckahoe, 0.05 to 1 percent of wrinkled gianthyssop herb, 0.1 to 1 percent of saffron, 0.5 to 2 percent of gynostemma pentaphylla, 0.1 to 3 percent of cicada slough, 3 to 5 percent of chrysanthemum, 1 to 2 percent of cassia seed, 1 to 3 percent of coix seed, 2 to 5 percent of malt, 0.1 to 3 percent of fresh cogongrass rhizome, 1 to 2 percent of dried ginger, 2 to 3 percent of blackberry, 1 to 3 percent of orange peel, 2 to 3 percent of fried tartary buckwheat, 1 to 3 percent of rose, 2 to 3 percent of sophora flower, 1 to 3 percent of formosan lattuce herb, 3 to 5 percent of white tea, 1 to 3 percent of hawthorn, 2 to 3 percent of lotus leaf, 1 to.
As a further embodiment of the invention, the substitutional tea is a composition which can generate a synergistic effect between at least one component for protecting cardiovascular and cerebrovascular by assisting in reducing blood fat and other components, and the composition comprises 3-5% of chrysanthemum, 0.1-2% of tuckahoe, 1-3% of orange peel, 2-3% of fried tartary buckwheat, 1-3% of rose, 0.5-2% of gynostemma pentaphylla, 1-2% of formosan lattuce herb and 3-5% of white tea;
or, as a further embodiment of the invention, the substitute tea is a composition which can generate a synergistic effect between at least one component and other components for protecting heart and cerebral vessels by assisting blood pressure reduction, and the composition comprises 1-3% of hawthorn, 2-3% of lotus leaf, 2-3% of fried tartary buckwheat, 1-3% of coix seed, 1-2% of cassia seed, 0.1-1% of saffron and 3-5% of white tea.
In the dietary food provided by the invention, one or more substitutional tea taking chrysanthemum, tuckahoe, gynostemma pentaphylla, broadleaf holly leaf and the like as main components has the functions of efficiently reducing blood fat, softening blood vessels, removing garbage in vivo and the like,
especially gynostemma pentaphylla, which has the functions of obviously reducing cholesterol (TCH), Triglyceride (TG), low-density lipoprotein (LDL), increasing high-density lipoprotein (HDL), protecting blood vessel inner wall cells, preventing lipid from depositing on blood vessel walls and resisting arteriosclerosis; in addition, the gynostemma pentaphylla and the saffron can generate a synergistic interaction effect, so that the blood circulation promoting function of a human body can be effectively improved, blood vessel garbage in the human body can be removed, the congestion can be relieved, and the blood fat and the blood pressure can be reduced;
in the aspects of degreasing, losing weight and resisting oxidation, the invention discovers that the ingredients such as cicada slough, chrysanthemum, cassia seed, coix seed, fried tartary buckwheat, sophora flower, ilex latifolia thumb, white tea, hawthorn, lotus leaf and the like have synergistic effect;
in the aspect of clearing heat and reducing internal heat, the invention discovers that the honeysuckle, the chrysanthemum, the bitter leaves, the sophora flower, the balsam pear, the lalang grass rhizome, the raw malt and other components have mutual synergistic action, and the synergistic action has obvious effects on removing chronic inflammatory reaction of an organism, preventing arteriosclerosis and the like.
The meal replacement powder provided by the invention comprises the following components in percentage by weight: 1 to 5 percent of sedum aizoon, 1 to 3 percent of sweet potato leaf, 0.5 to 3 percent of medlar bud, 1 to 3 percent of balsam pear, 0.5 to 2 percent of purslane, 1 to 2 percent of gynura bicolor, 0.5 to 2 percent of black fungus, 0.5 to 1 percent of tremella, 1 to 2 percent of calla, 1 to 3 percent of kiwi fruit, 0.1 to 2 percent of dried mulberry, 1 to 5 percent of sea-buckthorn pulp, 0.5 to 1 percent of spina date seed, 0.5 to 2 percent of dark plum, 1 to 2 percent of black rice, 1 to 2 percent of sorghum rice, 1 to 3 percent of red glutinous rice, 1 to 3 percent of quinoa, 1 to 2 percent of yellow rice, 2 to 3 percent of barley malt powder or wheat bud powder, 1 to 3 percent of black wheat, 1 to 2 percent of oat, 1 to 2 percent of tartary buckwheat, 1 to 2 percent of highland barley, 1 to 5 percent of yam, 0.5 to 1 percent of gorgon fruit, 0.5 to 1 percent, 1 to 3 percent of abalone mushroom, 0.5 to 1 percent of pleurotus eryngii, 1 to 3 percent of grifola frondosa, 1 to 2 percent of fiddlehead, 0.5 to 1 percent of flaxseed and 0.5 to 1 percent of chia seed.
As a further embodiment of the present invention, the nutritional meal replacement powder is a composition having a synergistic effect between at least one component and other components, and the composition comprises 2.8% of bitter gourd, 1% of purslane, 1.5% of gynura bicolor, 0.6% of spina date seed, 2% of red glutinous rice, 2% of quinoa rice, 2% of triticale, 1.2% of oat, 1.2% of tartary buckwheat, 1.5% of highland barley, 0.6% of gorgon euryale seed, 0.8% of coix seed, 0.6% of linseed, 0.5% of chia seed, barley malt powder or 2% of wheat germ powder.
According to the theory of traditional Chinese medicine, namely five-color five-viscera tonifying and the basic theory of homology of medicine and food, the meal replacement powder takes the coordination effect of all the components in the meal replacement powder on the organism to improve the functions of viscera and promote the absorption of nutrient substances, so that the effects of the five cereals and the grains are brought into full play, the blood fat, the blood pressure, the blood sugar and the cholesterol of the human body are obviously reduced, and the meal replacement powder has the effects of relieving the blockage of heart and cerebral arteries, tonifying the kidney and nourishing the stomach, resisting fatigue, enhancing the immunity and the like.
Especially, the quinoa rice can fully supplement various dietary fibers, vitamins and minerals required by human bodies, amino acids contained in seed coats of the quinoa are rich in variety, 9 kinds of essential amino acids required by human beings are contained, a lot of non-essential amino acids are contained, particularly lysine which most crops do not contain is enriched, mineral elements which are rich in variety and high in content are contained, and various vitamins required by normal metabolism of human bodies are contained, cholesterol and gluten are not contained, the sugar content, the fat content and the heat quantity are all low, and the quinoa rice has good adjuvant therapy effect on treating hypertension, hyperlipidemia and diabetes.
The meal replacement powder provided by the invention provides basic nutrition, corrects recessive deficiency of vitamins and minerals, and improves the immunity of the organism; the substitute tea is used as a daily beverage, and invisibly provides the capability of promoting blood circulation and removing blood stasis of an organism for protecting cardiovascular; the solid beverage further improves and consolidates the functions of the two components, strengthens the functions of activating blood circulation to dissipate blood stasis, reducing fat and expelling toxin, tranquilizing and allaying excitement, regulating blood pressure and protecting heart and cerebral vessels, and can exert the effect of assisting in conditioning heart and cerebral vessels, wherein 1+1+1 is far more than 3.
The eating method of the invention is as follows: the special meal replacement powder prepared by the invention is used for fat people on the basis of diet management, the original dosage of lipid-lowering or pressure-lowering medicines is taken in the first month, the original dosage of the lipid-lowering or pressure-lowering medicines is taken simultaneously, the cardiovascular and cerebrovascular medicines are protected, the type and dosage of western medicines are gradually reduced from the second month until the western medicines are completely stopped, the substitutive tea and the solid beverage are continuously taken for 1-3 months, so that the strengthening effect is achieved, and after three months, the life style and diet management is enhanced, and the conditioning effect is maintained.
Example 1 Effect of the dietary food of the present invention on blood pressure of rats and humans
The experiment uses the self-prepared solid beverage, the substitutive tea and the meal replacement powder to comprehensively carry out a rat intervention experiment and intervene the hypertension patient.
(1) Solid beverage formula
The artificial planting method comprises the following steps of artificially planting 10g of ginseng powder, 6g of acanthopanax sessiliflorus extract, 12g of eucommia male flower extract, 6g of radix puerariae extract, 10g of sophora flower bud extract, 24g of superfine celery powder, 12g of natto, 1g of gamma-aminobutyric acid, 1.5g of magnesium gluconate, 15mg of folic acid, 6g of lemon powder and stevioside, adjusting the sweetness and adding resistant dextrin to 100 g.
(2) Substitutional tea
24g of lotus leaf, 24g of balsam pear (dried), 20g of hawthorn, 16g of fried tartary buckwheat and 16g of Anji white tea are uniformly mixed together for backup
(3) Ultramicro meal replacement powder
18g of gynura bicolor (dried), 6g of spina date seed, 18g of black glutinous rice, 12g of quinoa rice, 12g of triticale, 12g of highland barley, 8g of gordon euryale seed, 8g of wheat malt (dried) and 6g of chia seed, and the raw materials are mixed and subjected to superfine grinding to prepare superfine powder with the particle size of 5-100 microns for later use.
(4) Respectively mixing 15g of solid beverage and ultramicro meal replacement powder with 70g of base material of common rat feed, and preparing into pressure-reducing feed; replacing 20g of tea, adding 150ml of double distilled water, steaming to 100ml, continuously steaming for three times to obtain 300ml of crude tea liquid, uniformly mixing 300ml of crude tea liquid, and continuously steaming in a rotary evaporator to obtain 100ml of concentrated tea liquid which is equivalent to 0.2g/ml of tea substitute.
(5) Influence of self-prepared solid beverage, meal replacement powder and tea replacement on blood pressure of spontaneous hypertension rats
First, normal rats were fed with hypotensive feed and perfused with 1ml of concentrated tea solution daily for 28 days as experimental group (n-12), and the other group was gavaged with normal rat feed and continuously distilled water for 28 days as control group, and blood pressure was recorded through the tail artery (n-12), and the results are shown in table 1.
TABLE 1 intervention test of solid beverage, tea substitute and meal replacement powder on rat body weight and blood pressure
Compared between the two groups, p is more than 0.05, which shows that the systolic pressure, the average pressure and the diastolic pressure of normal rats have no obvious difference in the whole experimental process when the dietary food prepared by the invention is fed to the rats around, and the body weight of the other two groups of rats has no obvious difference. The formula shows that the solid beverage, the substitutive tea and the meal replacement powder are combined, so that the blood pressure and the weight average of the body of a normal rat are not obviously influenced.
Then, spontaneous hypertensive rats were used as experimental animal models, 60 spontaneous hypertensive rats of 5 weeks old were divided into a negative control group, a positive control group and a comprehensive intervention group, the negative control group was given normal feed and gavage with 1 ml/day of double distilled water, the positive control group was given normal feed and gavage with 15 mg/Kg of nitrendipine, and the comprehensive intervention group was fed with the above antihypertensive feed and perfused with 1ml of concentrated tea solution for 28 consecutive days, and the blood pressure change law is as shown in table 2.
TABLE 2 Effect of dietary food consumption on rat systolic blood pressure (n-12/group)
| Group of | Week 1 | Week 2 | Week 3 | Week 4 |
| Negative control group | 149.3±13.1 | 168.9±8.9 | 179.2±6.3 | 190.8±15.4 |
| Positive control group | 148.3±6.4 | 153.1±7.5 | 161.1±8.9 | 163.6±10.7** |
| Comprehensive intervention group | 148.6±3.5 | 167.6±17.1 | 168.5±18.4 | 166.4±13.5** |
Note: compared with the negative control group, the difference is obvious (P is less than 0.05, P is less than 0.01).
TABLE 3 Effect of dietary food on average rat pressure/mmHg
| Group of | Week 1 | Week 2 | Week 3 | Week 4 |
| Negative control group | 100.3±11.7 | 112.8±17.1 | 130.3±9.6 | 139.5±9.2 |
| Positive control group | 107.3±10.2 | 112.3±13.3 | 119.4±18.7 | 113.7±9.2** |
| Comprehensive intervention group | 109.3±13.1 | 117.4±10.5 | 121.0±15.1 | 124.6±6.5* |
Note: the difference was significant compared to the negative control group (. about.P < 0.05,. about.P < 0.01).
TABLE 4 Effect of dietary food on rat diastolic blood pressure/mmHg
| Week 1 | Week 2 | Week 3 | Week 4 | |
| Negative control group | 82.6±7.6 | 98.5±20.5 | 113.4±4.5 | 117.3±10.1 |
| Positive control group | 83.9±10.1 | 97.9±24.4 | 93.7±18.0** | 86.2±8.7* |
| Comprehensive intervention group | 87.6±11.9 | 86.3±10.7 | 99.9±13.4* | 93.0±9.1* |
Note: compared with a negative control group, the difference is obvious (P is less than 0.05, P is less than 0.01 ═ P
As can be seen from tables 2 to 4, the blood pressure of the negative control group rats gradually increased with the increase of the feeding time. Compared with a negative control group, the systolic pressure and the average pressure of the rats in the positive control group are reduced to some extent from 3 weeks, the significant difference is very obvious when the rats reach 4 weeks, and the difference is not different from the positive control group, so that the diet food provided by the invention can reduce the blood pressure of the rats, reduce the load of the heart and the artery, and gradually enhance the pressure reduction effect along with the prolongation of the intervention time.
(6) Influence of self-prepared solid beverage, meal replacement powder and tea replacement on essential hypertension patients
39 patients who are diagnosed as hypertension for the first time and are not used with hypertension drugs are selected, the patients are aged 42-68 years old, 26 men and 13 women, 5 patients who reject third-level hypertension and severe cardiovascular and cerebrovascular diseases, the rest 34 patients (22 men and 12 women) use the self-prepared solid beverage of (1) under the strict monitoring of doctors, 10g of the self-prepared solid beverage is orally taken before breakfast and dinner every day, the self-prepared solid beverage is taken with warm boiled water, 30g of meal replacement powder prepared by (3) is used for patients with hyperlipidemia and obesity, the dinner is halved at the same time, and 10g of tea prepared by (2) is used for replacing tea for drinking every day. After a one-month feeding trial, 2 persons were withdrawn halfway, and the blood pressure and blood lipid changes of the remaining 32 persons (21 men and 11 women) were as follows.
TABLE 5 intervention test for hypertensive patients (n ═ 32)
Compared with the method before the intervention, the method has the advantages that,*:P＜0.05，**：P＜0.01
the results show that after the comprehensive intervention scheme is applied for 30 days, the weight of a patient is obviously reduced, the systolic pressure/diastolic pressure of the patient is obviously reduced, the serum triglyceride, the low-density lipoprotein cholesterol and the total cholesterol of the patient are all reduced, and more importantly, the high-density lipoprotein cholesterol is synchronously increased, so that the effects of losing weight, reducing fat and losing weight can be better achieved through the intervention of health management, diet, solid beverage and tea.
Example 2 Effect of the dietary food of the present invention on the blood lipids and atherosclerotic plaques in hyperlipidemic patients
The experiment applies the influence of self-prepared solid beverage, substituted tea and meal replacement powder on carotid plaque of a hyperlipemia patient, and the specific implementation steps are as follows:
(1) solid beverage formula
18g of red yeast rice, 16g of natto, 12g of acerola powder, 10g of phytosterol ester, 10g of hawthorn extract, 10g of eucommia male flower extract, 5g of ginseng powder, 15g of celery powder and stevioside, wherein the proper sweetness is adjusted, and the resistant dextrin is added to 100 g.
(2) Substitutional tea
25g of flos sophorae, 20g of chrysanthemum, 15g of semen cassiae, 15g of orange peel, 5g of broadleaf holly leaf and 20g of white tea, wherein the total amount is 100g, the amount is 10g per bag, and the drying is carried out for later use;
(3) ultramicro meal replacement powder
20g of celery powder, 14g of red glutinous rice, 14g of triticale, 12g of purslane (dried), 12g of highland barley, 8g of gordon euryale seed, 8g of wheat malt (dried), 6g of spina date seed and 6g of chia seed, mixing and carrying out superfine grinding to prepare superfine powder with the particle size of 5-100 microns for later use.
(4) Influence of combined application of solid beverage, substitutive tea and meal replacement powder on carotid plaque of patient with hyperlipidemia
For 64 patients in the first clinic, 42 patients with carotid plaque diameter larger than 1cm are found by carotid artery examination, except 8 patients with 3-grade hypertension and serious cardiovascular and cerebrovascular embolism, 44 patients (26 men and 18 women) use the self-prepared solid beverage of (1), take 10g of the beverage orally before breakfast and dinner every day and take the beverage with warm water, use the meal replacement powder of (3) for patients with hyperlipidemia and obesity 30g, reduce half of the dinner at the same time, and use the tea of (2) for tea instead of tea every day. After three months of the test feeding, the blood lipids and carotid plaques changed as follows.
TABLE 6 Effect of integrated intervention on hyperlipidemia and carotid plaque in patients with hyperlipidemia (n ═ 44)
| Item | Before intervention | Intervention 30 days | Intervention for 90 days |
| Carotid plaque | 1.53±0.17 | 1.32±0.11＊ | 1.01±0.11＊＊ |
| Triglyceride (mmol/L) | 2.96±0.59 | 2.63±0.23＊ | 2.17±0.46＊＊ |
| Low density lipoprotein cholesterol (mmol/L) | 3.98±0.12 | 3.54±0.31 | 3.33±0.16＊ |
| Total cholesterol (mmol/L) | 5.87±0.27 | 4.76±0.21＊ | 4.18±0.38＊ |
| High density lipoprotein cholesterol (mmol/L) | 0.89±0.03 | 0.99±0.04 | 1.03±0.03 |
Compared with the method before the intervention, the method has the advantages that,*:P＜0.05，**：P＜0.01
the results show that after the comprehensive intervention scheme is applied for 30 days, serum triglyceride, low-density lipoprotein cholesterol and total cholesterol are all reduced, carotid plaque is obviously reduced, and the effect of reducing lipid and carotid plaque is more obvious in three months (90 days), which indicates that the combined comprehensive intervention can play a role in reducing lipid and reducing carotid plaque while reducing lipid, reduce carotid plaque, reduce the degree of arteriosclerosis and play an obvious role in protecting cardiovascular and cerebrovascular diseases.
It will be understood by those of ordinary skill in the art that the foregoing embodiments are specific examples for carrying out the invention, and that various changes in form and details may be made therein without departing from the spirit and scope of the invention in practice.
Claims (9)
1. A dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health is characterized in that the conditioning food comprises: one or more of solid beverage, substituted tea and meal replacement powder;
wherein the solid beverage comprises one or more compositions consisting of any three or more of red yeast rice, natto, hawthorn powder (extract), acerola powder, phytosterol (ester), eucommia male flower (extract), ginseng powder, kudzu root (extract), noni ferment powder, celery seed (extract), celery powder, mulberry leaf (extract), inulin, black cherry (extract), cassia seed (extract), spina date seed (extract), acanthopanax sessiliflorus (extract), poria cocos (extract), lotus leaf (extract), gynostemma pentaphylla, rhizoma alismatis, sophora japonica, ligusticum wallichii powder (extract), docosahexaenoic acid (DHA) powder, vitamin E, liquorice, gamma-aminobutyric acid (GABA), magnesium gluconate and astaxanthin;
the substitute tea comprises one or more compositions consisting of any three or more than three components with synergistic effect in tuckahoe, agastache rugosus, saffron crocus, gynostemma pentaphylla, periostracum cicadae, chrysanthemum, cassia seed, coix seed, malt, fresh lalang grass rhizome, dried ginger, orange peel, fried tartary buckwheat, honeysuckle, blackberry, rose, sophora flower, ilex latifolia thumb, white tea, hawthorn, lotus leaf, spina date seed, Chinese date and bitter gourd;
the meal replacement powder comprises the ingredients of the edible vegetable and fruit, namely sedum aizoon, sweet potato leaves, medlar buds, balsam pears, purslane, gynura bicolor, black fungus, tremella, calla, kiwi fruit, dried mulberry, sea buckthorn pulp, spina date seeds and dark plums, and one or more compositions consisting of any three or more than three ingredients with synergistic effect in the cereal products, namely black rice, red glutinous rice, quinoa wheat, millet, barley bud powder or wheat bud powder, triticale, oat, tartary buckwheat, highland barley, Chinese yam, gorgon fruit, coix seed, almond, abalone mushroom, pleurotus eryngii, grifola, bracken, linseed and chia seeds.
2. The dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health as claimed in claim 1, wherein the dietary food is the solid beverage, and the solid beverage comprises the following components in percentage by weight: 2 to 5 percent of red yeast rice, 1 to 5 percent of natto, 1 to 3 percent of hawthorn powder (extract), 1 to 3 percent of acerola cherry powder, 1.5 to 3 percent of phytosterol (ester), 0.5 to 3 percent of eucommia male flower (extract), 1 to 3 percent of ginseng powder, 1 to 5 percent of kudzu root (extract), 0.1 to 3 percent of noni fruit ferment powder, 1 to 2 percent of celery seed (extract), 3 to 5 percent of celery powder, 1 to 3 percent of mulberry leaf (extract), 0.5 to 2 percent of inulin, 1 to 5 percent of black cherry (extract), 1 to 3 percent of cassia seed (extract), 1 to 2 percent of spina date seed (extract), 0.5 to 3 percent of acanthopanax sessiliflorus (extract), 0.1 to 2 percent of tuckahoe (extract), 1 to 3 percent of lotus leaf (extract), GABA, 0.5 to 2 percent of gynostemma pentaphylla, 0.1 to 2 percent of rhizoma alismatis, 0.1 to 2 percent of rice, 0.1-2% of ligusticum wallichii powder (extract), 0.5-2% of DHA powder, 0.001-0.1% of vitamin E, 0.5-1.5% of liquorice, 0.1-0.8% of GABA, 0.05-0.75% of magnesium gluconate and 1-3% of astaxanthin.
3. The dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health as claimed in claim 1, wherein the dietary food is the substitute tea, and the substitute tea comprises the following components in percentage by weight: 1 to 3 percent of honeysuckle, 0.1 to 2 percent of tuckahoe, 0.05 to 1 percent of wrinkled gianthyssop herb, 0.1 to 1 percent of saffron, 0.5 to 2 percent of gynostemma pentaphylla, 0.1 to 3 percent of cicada slough, 3 to 5 percent of chrysanthemum, 1 to 2 percent of cassia seed, 1 to 3 percent of coix seed, 2 to 5 percent of malt, 0.1 to 3 percent of fresh cogongrass rhizome, 1 to 2 percent of dried ginger, 2 to 3 percent of blackberry, 1 to 3 percent of orange peel, 2 to 3 percent of fried tartary buckwheat, 1 to 3 percent of rose, 2 to 3 percent of sophora flower, 1 to 3 percent of formosan lattuce herb, 3 to 5 percent of white tea, 1 to 3 percent of hawthorn, 2 to 3 percent of lotus leaf, 1.
4. The dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health as claimed in claim 1, wherein the dietary food is the meal replacement powder, and the meal replacement powder comprises the following components in percentage by weight: 1 to 5 percent of sedum aizoon, 1 to 3 percent of sweet potato leaf, 0.5 to 3 percent of medlar bud, 1 to 3 percent of balsam pear, 0.5 to 2 percent of purslane, 1 to 2 percent of gynura bicolor, 0.5 to 2 percent of black fungus, 0.5 to 1 percent of tremella, 1 to 2 percent of calla, 1 to 3 percent of kiwi fruit, 0.1 to 2 percent of dried mulberry, 1 to 5 percent of sea-buckthorn pulp, 0.5 to 1 percent of spina date seed, 0.5 to 2 percent of dark plum, 1 to 2 percent of black rice, 1 to 2 percent of sorghum rice, 1 to 3 percent of red glutinous rice, 1 to 3 percent of quinoa, 1 to 2 percent of yellow rice, 2 to 3 percent of barley malt powder or wheat bud powder, 1 to 3 percent of black wheat, 1 to 2 percent of oat, 1 to 2 percent of tartary buckwheat, 1 to 2 percent of highland barley, 1 to 5 percent of yam, 0.5 to 1 percent of abalone, 0.5 to, 0.5 to 1 percent of pleurotus eryngii, 1 to 3 percent of grifola frondosa, 1 to 2 percent of fiddlehead, 0.5 to 1 percent of flaxseed and 0.5 to 1 percent of chia seed.
5. The dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health is characterized in that the solid beverage is a composition for assisting in reducing blood fat and protecting cardiovascular and cerebrovascular by generating synergistic effect between at least one component and other components, and the composition comprises 2-5% of red yeast rice, 2-5% of natto, 1-3% of hawthorn powder (extract), 1-3% of acerola powder, 1.5-3% of phytosterol (ester), 1-3% of eucommia male flower extract, 1-3% of ginseng powder and 0.001-0.1% of vitamin E.
6. The dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health is characterized in that the solid beverage is a composition for assisting in reducing blood pressure and protecting cardiovascular and cerebrovascular at least one component and generating synergistic effect with other components, and the composition comprises 1-3% of ginseng powder, 0.5-2% of acanthopanax sessiliflorus extract, 0.5-2% of eucommia male flower extract, 0.5-1.5% of sophora flower bud, 1.5-3% of lotus leaf extract, 1-2% of celery seed extract, 3-5% of celery powder, 1-2% of natto, 1-2% of cassia seed, 1-2% of spina date seed, 0.5-1.5% of liquorice, 0.5-1.5% of poria cocos, 0.5-0.8% of GABA, 0.05-0.75% of magnesium gluconate and 1-3% of astaxanthin.
7. The dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health as claimed in claim 3, wherein the substitute tea is a composition for assisting in reducing blood fat and protecting cardiovascular and cerebrovascular, and at least one component of the composition has a synergistic effect with other components, and the composition comprises 3% -5% of chrysanthemum, 0.1% -2% of poria cocos, 1% -3% of orange peel, 2% -3% of fried tartary buckwheat, 1% -3% of rose, 0.5% -2% of gynostemma pentaphylla, 1% -2% of broadleaf holly leaf and 3% -5% of white tea.
8. The dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health according to claim 3, wherein the substitute tea is a composition for assisting in reducing blood pressure and protecting cardiovascular and cerebrovascular and generating a synergistic effect between at least one component and other components, and the composition comprises 1% -3% of hawthorn, 2% -3% of lotus leaf, 2% -3% of fried tartary buckwheat, 1% -3% of coix seed, 1% -2% of cassia seed, 0.1% -1% of saffron crocus and 3% -5% of white tea.
9. The dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health as claimed in claim 4, wherein the nutritional meal replacement powder is a composition which generates a synergistic effect between at least one component and other components, and the composition comprises 2.8% of balsam pear, 1% of purslane, 1.5% of gynura bicolor, 0.6% of spina date seed, 2% of red glutinous rice, 2% of quinoa, 2% of triticale, 1.2% of oat, 1.2% of tartary buckwheat, 1.5% of highland barley, 0.6% of gorgon fruit, 0.8% of coix seed, 0.6% of linseed, 0.5% of chia seed, and 2% of barley malt powder or wheat malt powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911340843.5A CN112931741A (en) | 2019-12-23 | 2019-12-23 | Dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911340843.5A CN112931741A (en) | 2019-12-23 | 2019-12-23 | Dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112931741A true CN112931741A (en) | 2021-06-11 |
Family
ID=76234439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911340843.5A Withdrawn CN112931741A (en) | 2019-12-23 | 2019-12-23 | Dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112931741A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113679786A (en) * | 2021-07-09 | 2021-11-23 | 杭州雪域生物技术有限公司 | Composition of red yeast rice, agaricus blazei murill and grifola frondosa and preparation method and application thereof |
| CN114209058A (en) * | 2021-12-15 | 2022-03-22 | 本元大健康科技产业(广东)有限公司 | Preparation for preventing hypertension, hyperlipidemia and hyperglycemia and preparation method thereof |
| CN114223895A (en) * | 2021-11-09 | 2022-03-25 | 上海椿龄健康管理有限公司 | Food formula for preventing and treating hyperlipidemia |
| CN114403434A (en) * | 2022-01-12 | 2022-04-29 | 山东贝隆杜仲生物工程有限公司 | Composition with blood pressure lowering effect and prepared from eucommia ulmoides as raw material and preparation method |
| CN114868891A (en) * | 2022-03-26 | 2022-08-09 | 大医声科技(北京)有限公司 | Nutrient formula suitable for patients with cardiovascular and cerebrovascular diseases |
| CN114868917A (en) * | 2022-04-27 | 2022-08-09 | 上海诚明圣源生物科技有限公司 | Health-care food composition for assisting in reducing blood fat and preparation method and application thereof |
| CN116392562A (en) * | 2022-05-30 | 2023-07-07 | 常德集智生物科技有限公司 | Beverage and application and preparation method thereof |
-
2019
- 2019-12-23 CN CN201911340843.5A patent/CN112931741A/en not_active Withdrawn
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113679786A (en) * | 2021-07-09 | 2021-11-23 | 杭州雪域生物技术有限公司 | Composition of red yeast rice, agaricus blazei murill and grifola frondosa and preparation method and application thereof |
| CN114223895A (en) * | 2021-11-09 | 2022-03-25 | 上海椿龄健康管理有限公司 | Food formula for preventing and treating hyperlipidemia |
| CN114209058A (en) * | 2021-12-15 | 2022-03-22 | 本元大健康科技产业(广东)有限公司 | Preparation for preventing hypertension, hyperlipidemia and hyperglycemia and preparation method thereof |
| CN114403434A (en) * | 2022-01-12 | 2022-04-29 | 山东贝隆杜仲生物工程有限公司 | Composition with blood pressure lowering effect and prepared from eucommia ulmoides as raw material and preparation method |
| CN114868891A (en) * | 2022-03-26 | 2022-08-09 | 大医声科技(北京)有限公司 | Nutrient formula suitable for patients with cardiovascular and cerebrovascular diseases |
| CN114868917A (en) * | 2022-04-27 | 2022-08-09 | 上海诚明圣源生物科技有限公司 | Health-care food composition for assisting in reducing blood fat and preparation method and application thereof |
| CN116392562A (en) * | 2022-05-30 | 2023-07-07 | 常德集智生物科技有限公司 | Beverage and application and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112931741A (en) | Dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health | |
| US6413545B1 (en) | Diet composition and method of weight management | |
| US8227013B2 (en) | Dietary nutritional supplements for healthcare | |
| CN103099089B (en) | Health-care product for reducing blood sugar and blood pressure, relaxing bowels, losing weight, resisting fatigue and improving sexual function and production technology thereof | |
| CN101473953B (en) | Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application | |
| CN105077236B (en) | Compound special meals nutrient powder of the highland barley of auxiliary hyperglycemic and preparation method thereof | |
| CN104643080B (en) | Combined formula of three-day food exchange body shaping product and eating method | |
| CN102813120B (en) | Anti-cancer sea cucumber sugar-reducing flour and preparation method thereof | |
| KR20150051020A (en) | Composition For Anti-obesity And Diet | |
| CN106174474A (en) | A kind of it is applicable to the special dietary seafood that Patients with Cardiovascular/Cerebrovascular Diseases is edible | |
| CN111096416A (en) | Diet-depriving composition for weight-losing meal replacement and preparation method thereof | |
| CN108618126A (en) | A kind of Chinese medicine compound prescription weight-reducing special diet food and preparation method thereof | |
| CN111227153A (en) | Dietary food for whitening, detoxifying and slimming | |
| CN109770368A (en) | A kind of more taste plant polypeptide weight losing meal-replacing powders and preparation method thereof | |
| CN103844249A (en) | Nutritional food, and preparation method thereof | |
| CN106418501A (en) | Healthcare food with weight reducing function | |
| CN111771988A (en) | Nutritional food suitable for diabetic patients and preparation method thereof | |
| Tufail et al. | Garden cress seeds: a review on nutritional composition, therapeutic potential, and industrial utilization | |
| EP1889638A1 (en) | Medicaments and food for treatment or prevention of obesity and/or diabetes containing cicer arietinum extract | |
| WO2023100764A1 (en) | Composition for preventing, improving or alleviating symptoms relating to qi deficiency and/or blood deficiency | |
| CN109007820A (en) | A kind of composition and its application | |
| JP2007131605A (en) | Indefinite complaint-improving composition and food | |
| CN108013459A (en) | A kind of health food with fat-reducing and beauty function and preparation method thereof | |
| CN102224927B (en) | Spleen tonifying and brain strengthening healthcare product | |
| CN110651983A (en) | High-protein nutrition powder and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20210611 |
|
| WW01 | Invention patent application withdrawn after publication |